OCUL · Ocular Therapeutix Inc. Common Stock
View on chartInsiders & Stakes
| SUMMER ROAD LLC 10% Owner | ▲ Buy | Open Market | 8,591,401 Shares held | 2/26/2024 | View profile |
| Pravin Dugel Executive Chairman | ▼ Sell | Gift | 744,903 Shares held | 8/25/2026 | View profile |
| Antony C. Mattessich President and CEO | ▼ Sell | Open Market | 588,701 Shares held | 2/5/2024 | View profile |
| Donald Notman Chief Operating Officer | ▼ Sell | Open Market | 366,529 Shares held | 8/31/2026 | View profile |
| Sanjay Nayak Chief Strategy Officer | ▼ Sell | Open Market | 326,898 Shares held | 8/24/2026 | View profile |
| Goldstein Michael H. President, Ophthalmology & CMO | ▲ Buy | Grant | 313,335 Shares held | 2/3/2022 | View profile |
| Jeffrey S. Heier Director | ▼ Sell | Open Market | 307,457 Shares held | 10/2/2026 | View profile |
| Nadia Waheed Chief Medical Officer | ▼ Sell | Open Market | 300,079 Shares held | 6/3/2026 | View profile |
| Richard L. Lindstrom, MD Director | ▲ Buy | Grant | 260,933 Shares held | 6/10/2026 | View profile |
| Namrata Saroj Chief Business Officer | ▲ Buy | Grant | 254,620 Shares held | 1/2/2026 | View profile |
| Peter Kaiser Chief Development Officer | ▼ Sell | Open Market | 254,388 Shares held | 10/2/2026 | View profile |
| Steve Lawrence Meyers Chief Commercial Officer | ▲ Buy | Grant | 217,628 Shares held | 1/2/2026 | View profile |
| Strassburger Philip C. General Counsel | ▼ Sell | Open Market | 161,493 Shares held | 2/5/2024 | View profile |
| Ozden Rabia Gurses Chief Medical Officer | ▼ Sell | Open Market | 153,054 Shares held | 2/5/2024 | View profile |
| Todd Anderman Chief Legal Officer | ▲ Buy | Grant | 152,468 Shares held | 1/2/2026 | View profile |
| David Wayne Robinson Global CCO | ▲ Buy | Grant | 136,000 Shares held | 1/21/2026 | View profile |
| White Christopher G Chief Business Officer | ▼ Sell | Open Market | 123,689 Shares held | 2/5/2024 | View profile |
| Charles M. Warden Director | ▲ Buy | Grant | 100,464 Shares held | 6/10/2026 | View profile |
| Jason Shand Robins Chief Financial Officer | ▲ Buy | Grant | 68,097 Shares held | 6/10/2026 | View profile |
| Leslie J. Williams Director | ▲ Buy | Grant | 65,433 Shares held | 6/10/2026 | View profile |
| Adrienne L. Graves Director | ▲ Buy | Grant | 64,000 Shares held | 6/10/2026 | View profile |
| Seung Suh Hong Director | ▲ Buy | Grant | 60,933 Shares held | 6/10/2026 | View profile |
| Merilee Raines Director | ▲ Buy | Grant | 60,933 Shares held | 6/10/2026 | View profile |
Transaction History
| Peter Kaiser | ▼ Sell | Open Market | 9,990 | $70K | 10/2/2026 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 10,869 | $77K | 10/2/2026 |
| Donald Notman | ▼ Sell | Open Market | 1,099 | $11K | 8/31/2026 |
| Pravin Dugel | ▼ Sell | Gift | 50,092 | $0 | 8/25/2026 |
| Pravin Dugel | ▼ Sell | Gift | 50,092 | $0 | 8/25/2026 |
| Peter Kaiser | ▼ Sell | Open Market | 3,035 | $33K | 8/24/2026 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,897 | $20K | 8/24/2026 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 3,296 | $36K | 8/24/2026 |
| Pravin Dugel | ▼ Sell | Open Market | 21,649 | $233K | 8/24/2026 |
| Pravin Dugel | ▼ Sell | Gift | 50,092 | $0 | 6/16/2026 |
| Pravin Dugel | ▼ Sell | Gift | 50,092 | $0 | 6/16/2026 |
| Seung Suh Hong | ▲ Buy | Grant | 14,000 | $0 | 6/10/2026 |
| Richard L. Lindstrom, MD | ▲ Buy | Grant | 14,000 | $0 | 6/10/2026 |
| Merilee Raines | ▲ Buy | Grant | 14,000 | $0 | 6/10/2026 |
| Charles M. Warden | ▲ Buy | Grant | 14,000 | $0 | 6/10/2026 |
| Adrienne L. Graves | ▲ Buy | Grant | 14,000 | $0 | 6/10/2026 |
| Jason Shand Robins | ▲ Buy | Grant | 15,441 | $0 | 6/10/2026 |
| Leslie J. Williams | ▲ Buy | Grant | 14,000 | $0 | 6/10/2026 |
| Nadia Waheed | ▼ Sell | Open Market | 14,828 | $123K | 6/3/2026 |
| Pravin Dugel | ▼ Sell | Gift | 394,696 | $0 | 5/28/2026 |
| Pravin Dugel | ▼ Sell | Gift | 394,696 | $0 | 5/28/2026 |
| Pravin Dugel | ▼ Sell | Open Market | 21,156 | $173K | 5/26/2026 |
| Peter Kaiser | ▼ Sell | Open Market | 2,967 | $24K | 5/26/2026 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 3,018 | $25K | 5/26/2026 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,858 | $15K | 5/26/2026 |
| Pravin Dugel | ▼ Sell | Gift | 394,696 | $0 | 4/9/2026 |
| Pravin Dugel | ▼ Sell | Gift | 394,696 | $0 | 4/9/2026 |
| Pravin Dugel | ▼ Sell | Open Market | 20,056 | $166K | 2/23/2026 |
| Peter Kaiser | ▼ Sell | Open Market | 2,810 | $23K | 2/23/2026 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 3,057 | $25K | 2/23/2026 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,759 | $15K | 2/23/2026 |
| Nadia Waheed | ▼ Sell | Open Market | 3,510 | $27K | 2/20/2026 |
| Richard L. Lindstrom, MD | ▲ Buy | Open Market | 60,229 | $461K | 2/20/2026 |
| Donald Notman | ▼ Sell | Open Market | 11,446 | $103K | 2/12/2026 |
| Sanjay Nayak | ▼ Sell | Open Market | 10,348 | $94K | 2/12/2026 |
| Pravin Dugel | ▼ Sell | Open Market | 124,882 | $1.1M | 2/12/2026 |
| Nadia Waheed | ▼ Sell | Open Market | 7,863 | $71K | 2/12/2026 |
| Donald Notman | ▼ Sell | Open Market | 6,035 | $52K | 2/4/2026 |
| Donald Notman | ▼ Sell | Open Market | 5,455 | $50K | 2/2/2026 |
| David Wayne Robinson | ▲ Buy | Grant | 136,000 | $0 | 1/21/2026 |
| Todd Anderman | ▲ Buy | Grant | 64,900 | $0 | 1/2/2026 |
| Steve Lawrence Meyers | ▲ Buy | Grant | 64,900 | $0 | 1/2/2026 |
| Sanjay Nayak | ▲ Buy | Grant | 64,900 | $0 | 1/2/2026 |
| Peter Kaiser | ▲ Buy | Grant | 79,112 | $0 | 1/2/2026 |
| Namrata Saroj | ▲ Buy | Grant | 79,112 | $0 | 1/2/2026 |
| Nadia Waheed | ▲ Buy | Grant | 79,112 | $0 | 1/2/2026 |
| Jeffrey S. Heier | ▲ Buy | Grant | 79,112 | $0 | 1/2/2026 |
| Donald Notman | ▲ Buy | Grant | 79,112 | $0 | 1/2/2026 |
| Pravin Dugel | ▼ Sell | Gift | 49,754 | $0 | 11/26/2025 |
| Pravin Dugel | ▼ Sell | Gift | 49,754 | $0 | 11/26/2025 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,878 | $23K | 11/24/2025 |
| Pravin Dugel | ▼ Sell | Open Market | 19,530 | $235K | 11/24/2025 |
| Peter Kaiser | ▼ Sell | Open Market | 3,007 | $36K | 11/24/2025 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 3,469 | $42K | 11/24/2025 |
| Namrata Saroj | ▼ Sell | Open Market | 25,865 | $278K | 11/5/2025 |
| Todd Anderman | ▼ Sell | Open Market | 11,132 | $137K | 10/8/2025 |
| Peter Kaiser | ▼ Sell | Open Market | 9,653 | $106K | 10/2/2025 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 10,502 | $116K | 10/2/2025 |
| Pravin Dugel | ▼ Sell | Gift | 49,754 | $0 | 9/9/2025 |
| Pravin Dugel | ▼ Sell | Gift | 49,754 | $0 | 9/9/2025 |
| Donald Notman | ▼ Sell | Open Market | 1,066 | $13K | 9/2/2025 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,885 | $23K | 8/25/2025 |
| Pravin Dugel | ▼ Sell | Open Market | 21,494 | $259K | 8/25/2025 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 3,063 | $37K | 8/25/2025 |
| Peter Kaiser | ▼ Sell | Open Market | 3,011 | $36K | 8/25/2025 |
| Nadia Waheed | ▲ Buy | Grant | 40,363 | $0 | 8/12/2025 |
| Pravin Dugel | ▼ Sell | Gift | 250,361 | $0 | 8/11/2025 |
| Pravin Dugel | ▼ Sell | Gift | 50,029 | $0 | 6/12/2025 |
| Merilee Raines | ▲ Buy | Grant | 14,000 | $0 | 6/11/2025 |
| Richard L. Lindstrom, MD | ▲ Buy | Grant | 14,000 | $0 | 6/11/2025 |
| Adrienne L. Graves | ▲ Buy | Grant | 14,000 | $0 | 6/11/2025 |
| Seung Suh Hong | ▲ Buy | Grant | 14,000 | $0 | 6/11/2025 |
| Leslie J. Williams | ▲ Buy | Grant | 14,000 | $0 | 6/11/2025 |
| Charles M. Warden | ▲ Buy | Grant | 14,000 | $0 | 6/11/2025 |
| Nadia Waheed | ▼ Sell | Open Market | 13,861 | $112K | 6/2/2025 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,862 | $13K | 5/23/2025 |
| Peter Kaiser | ▼ Sell | Open Market | 2,974 | $21K | 5/23/2025 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 3,024 | $22K | 5/23/2025 |
| Pravin Dugel | ▼ Sell | Open Market | 21,219 | $152K | 5/23/2025 |
| Richard L. Lindstrom, MD | ▲ Buy | Open Market | 10,000 | $70K | 5/8/2025 |
| Pravin Dugel | ▼ Sell | Gift | 200,332 | $0 | 4/28/2025 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,895 | $13K | 2/24/2025 |
| Pravin Dugel | ▼ Sell | Open Market | 21,475 | $148K | 2/24/2025 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 3,061 | $21K | 2/24/2025 |
| Peter Kaiser | ▼ Sell | Open Market | 3,009 | $21K | 2/24/2025 |
| Sanjay Nayak | ▲ Buy | Grant | 111,000 | $0 | 2/11/2025 |
| Donald Notman | ▲ Buy | Grant | 115,000 | $0 | 2/11/2025 |
| Pravin Dugel | ▲ Buy | Grant | 1,250,000 | $0 | 2/11/2025 |
| Pravin Dugel | ▲ Buy | Grant | 1,500,000 | $0 | 2/11/2025 |
| Nadia Waheed | ▲ Buy | Grant | 79,000 | $0 | 2/11/2025 |
| Donald Notman | ▼ Sell | Open Market | 11,119 | $87K | 2/4/2025 |
| Donald Notman | ▼ Sell | Open Market | 6,301 | $49K | 1/31/2025 |
| Jeffrey S. Heier | ▼ Sell | Open Market | 2,948 | $27K | 11/25/2024 |
| Peter Kaiser | ▼ Sell | Open Market | 2,897 | $26K | 11/25/2024 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,814 | $16K | 11/25/2024 |
| Pravin Dugel | ▼ Sell | Open Market | 20,680 | $186K | 11/25/2024 |
| Todd Anderman | ▲ Buy | Grant | 98,700 | $0 | 10/7/2024 |
| Peter Kaiser | ▲ Buy | Grant | 100,000 | $0 | 10/2/2024 |
| Jeffrey S. Heier | ▲ Buy | Grant | 100,000 | $0 | 10/2/2024 |
| Donald Notman | ▲ Buy | Grant | 11,034 | $0 | 8/29/2024 |
| Sanjay Nayak | ▼ Sell | Open Market | 1,832 | $17K | 8/23/2024 |
| Pravin Dugel | ▼ Sell | Open Market | 20,880 | $188K | 8/23/2024 |
| Seung Suh Hong | ▲ Buy | Grant | 12,000 | $0 | 7/24/2024 |
| Merilee Raines | ▲ Buy | Grant | 12,000 | $0 | 7/24/2024 |
| Richard L. Lindstrom, MD | ▲ Buy | Grant | 12,000 | $0 | 7/24/2024 |
| Leslie J. Williams | ▲ Buy | Grant | 12,000 | $0 | 7/24/2024 |
| Charles M. Warden | ▲ Buy | Grant | 12,000 | $0 | 7/24/2024 |
| Adrienne L. Graves | ▲ Buy | Grant | 12,000 | $0 | 7/24/2024 |
| Nadia Waheed | ▲ Buy | Grant | 141,666 | $0 | 6/1/2024 |
| Sanjay Nayak | ▼ Sell | Open Market | 2,274 | $13K | 5/23/2024 |
| Pravin Dugel | ▼ Sell | Open Market | 21,626 | $125K | 5/23/2024 |
| Richard L. Lindstrom, MD | ▲ Buy | Option Exercise | 18,939 | $167K | 2/27/2024 |
| Richard L. Lindstrom, MD | ▲ Buy | Option Exercise | 11,363 | $100K | 2/27/2024 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 930,851 | $7.0M | 2/26/2024 |
| Pravin Dugel | ▲ Buy | Grant | 854,979 | $0 | 2/22/2024 |
| Sanjay Nayak | ▲ Buy | Grant | 80,300 | $0 | 2/22/2024 |
| Antony C. Mattessich | ▼ Sell | Open Market | 19,642 | $95K | 2/5/2024 |
| Ozden Rabia Gurses | ▼ Sell | Open Market | 6,346 | $31K | 2/5/2024 |
| Donald Notman | ▼ Sell | Open Market | 6,212 | $30K | 2/5/2024 |
| White Christopher G | ▼ Sell | Open Market | 5,910 | $29K | 2/5/2024 |
| Strassburger Philip C. | ▼ Sell | Open Market | 6,029 | $29K | 2/5/2024 |
| Antony C. Mattessich | ▲ Buy | Grant | 180,400 | $0 | 2/3/2024 |
| Donald Notman | ▲ Buy | Grant | 61,636 | $0 | 2/3/2024 |
| Ozden Rabia Gurses | ▲ Buy | Grant | 66,633 | $0 | 2/3/2024 |
| White Christopher G | ▲ Buy | Grant | 39,980 | $0 | 2/3/2024 |
| Strassburger Philip C. | ▲ Buy | Grant | 58,304 | $0 | 2/3/2024 |
| Donald Notman | ▼ Sell | Open Market | 6,433 | $32K | 1/31/2024 |
| Ozden Rabia Gurses | ▼ Sell | Open Market | 7,764 | $38K | 1/31/2024 |
| Strassburger Philip C. | ▼ Sell | Open Market | 6,831 | $34K | 1/31/2024 |
| White Christopher G | ▼ Sell | Open Market | 5,147 | $25K | 1/31/2024 |
| Antony C. Mattessich | ▼ Sell | Open Market | 18,338 | $91K | 1/31/2024 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 1,538,461 | $5.0M | 12/14/2023 |
| Antony C. Mattessich | ▲ Buy | Open Market | 6,500 | $25K | 8/30/2023 |
| Adrienne L. Graves | ▲ Buy | Grant | 24,000 | $0 | 7/10/2023 |
| Ozden Rabia Gurses | ▼ Sell | Open Market | 832 | $4K | 7/7/2023 |
| Richard L. Lindstrom, MD | ▲ Buy | Grant | 12,000 | $0 | 6/14/2023 |
| Merilee Raines | ▲ Buy | Grant | 12,000 | $0 | 6/14/2023 |
| Leslie J. Williams | ▲ Buy | Grant | 12,000 | $0 | 6/14/2023 |
| Charles M. Warden | ▲ Buy | Grant | 12,000 | $0 | 6/14/2023 |
| Seung Suh Hong | ▲ Buy | Grant | 12,000 | $0 | 6/14/2023 |
| Jeffrey S. Heier | ▲ Buy | Grant | 12,000 | $0 | 6/14/2023 |
| Donald Notman | ▼ Sell | Open Market | 6,476 | $27K | 2/6/2023 |
| Antony C. Mattessich | ▼ Sell | Open Market | 19,669 | $83K | 2/6/2023 |
| Strassburger Philip C. | ▼ Sell | Open Market | 6,181 | $26K | 2/6/2023 |
| Ozden Rabia Gurses | ▼ Sell | Open Market | 6,416 | $27K | 2/6/2023 |
| White Christopher G | ▼ Sell | Open Market | 5,829 | $25K | 2/6/2023 |
| White Christopher G | ▲ Buy | Grant | 44,444 | $0 | 1/30/2023 |
| Strassburger Philip C. | ▲ Buy | Grant | 55,556 | $0 | 1/30/2023 |
| Ozden Rabia Gurses | ▲ Buy | Grant | 55,556 | $0 | 1/30/2023 |
| Donald Notman | ▲ Buy | Grant | 55,556 | $0 | 1/30/2023 |
| Antony C. Mattessich | ▲ Buy | Grant | 176,300 | $0 | 1/30/2023 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 7,328 | $26K | 11/7/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 10,000 | $39K | 10/11/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 10,000 | $40K | 10/10/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 18,800 | $76K | 9/29/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 1,200 | $5K | 9/28/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 130,000 | $608K | 9/27/2022 |
| Ozden Rabia Gurses | ▲ Buy | Grant | 6,667 | $0 | 7/1/2022 |
| Leslie J. Williams | ▲ Buy | Grant | 8,933 | $0 | 6/16/2022 |
| Jeffrey S. Heier | ▲ Buy | Grant | 8,933 | $0 | 6/16/2022 |
| Richard L. Lindstrom, MD | ▲ Buy | Grant | 8,933 | $0 | 6/16/2022 |
| Seung Suh Hong | ▲ Buy | Grant | 8,933 | $0 | 6/16/2022 |
| Charles M. Warden | ▲ Buy | Grant | 8,933 | $0 | 6/16/2022 |
| Merilee Raines | ▲ Buy | Grant | 8,933 | $0 | 6/16/2022 |
| Jeffrey S. Heier | ▲ Buy | Open Market | 15,000 | $46K | 5/12/2022 |
| Richard L. Lindstrom, MD | ▲ Buy | Option Exercise | 9,469 | $12K | 5/12/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 10,000 | $48K | 2/23/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 40,000 | $200K | 2/18/2022 |
| Strassburger Philip C. | ▲ Buy | Grant | 50,000 | $0 | 2/3/2022 |
| Donald Notman | ▲ Buy | Grant | 55,556 | $0 | 2/3/2022 |
| White Christopher G | ▲ Buy | Grant | 50,000 | $0 | 2/3/2022 |
| Goldstein Michael H. | ▲ Buy | Grant | 63,333 | $0 | 2/3/2022 |
| Antony C. Mattessich | ▲ Buy | Grant | 186,750 | $0 | 2/3/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 4,023 | $21K | 1/28/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 1,477 | $8K | 1/27/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 44,400 | $236K | 1/24/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 12,152 | $68K | 1/21/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 17,948 | $102K | 1/20/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 6,807 | $41K | 1/18/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 33,193 | $200K | 1/14/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 10,000 | $62K | 1/13/2022 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 15,000 | $93K | 12/15/2021 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 29,490 | $189K | 12/14/2021 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 10,510 | $68K | 12/13/2021 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 30,000 | $199K | 12/10/2021 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 5,300 | $36K | 12/8/2021 |
| SUMMER ROAD LLC | ▲ Buy | Open Market | 55,600 | $341K | 12/6/2021 |
| Antony C. Mattessich | ▲ Buy | Open Market | 5,000 | $49K | 8/20/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
OCUL: UBS initiates coverage and Nasdaq grant filing reported
UBS has started coverage of Ocular Therapeutix and set a price target of $14. The company also disclosed inducement grants in compliance with Nasdaq Listing Rule 5635(c)(4). OCUL presented its latest data at the Euretina 2026 conference, highlighting ongoing development efforts. Analyst commentary this week varies, with some listing the stock among top healthcare picks while others note its unprofitable status.
OCUL: UBS initiates coverage and Nasdaq grant filing reported. UBS has started coverage of Ocular Therapeutix and set a price target of $14. The company also disclosed inducement grants in compliance with Nasdaq Listing Rule 5635(c)(4). OCUL presented its latest data at the Euretina 2026 conference, highlighting ongoing development efforts. Analyst commentary this week varies, with some listing the stock among top healthcare picks while others note its unprofitable status.